GENEVA, July 21 -- ADARX PHARMACEUTICALS, INC. (5871 Oberlin DriveSuite 200San Diego, CA 92121) filed a patent application (PCT/US2024/060424) for "COMPLEMENT FACTOR B-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF" on Dec 16, 2024. With publication no. WO/2025/151250, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Zhen (c/o Adarx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), CLAEBOE, Christopher (c/o Adarx Pharmaceuticals, Inc.5871 Oberlin Drive, Suite 200San Diego, CA 92121), GREBLIKAS...